143 related articles for article (PubMed ID: 6431985)
1. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.
Moody DE; Reddy JK; Azarnoff DL
Biochem Pharmacol; 1984 Aug; 33(16):2591-7. PubMed ID: 6431985
[TBL] [Abstract][Full Text] [Related]
2. Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.
Reddy JK; Moody DE; Azarnoff DL; Tomarelli RM
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):51-7. PubMed ID: 851495
[TBL] [Abstract][Full Text] [Related]
3. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
Reddy JK; Azarnoff DL; Sirtori CR
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
[TBL] [Abstract][Full Text] [Related]
4. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
Reddy JK; Krishnakantha TP
Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
6. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
Moody DE; Reddy JK
Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
[TBL] [Abstract][Full Text] [Related]
7. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
8. Properties of purified carnitine acyltransferases of mouse liver peroxisomes.
Farrell SO; Fiol CJ; Reddy JK; Bieber LL
J Biol Chem; 1984 Nov; 259(21):13089-95. PubMed ID: 6436243
[TBL] [Abstract][Full Text] [Related]
9. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
[TBL] [Abstract][Full Text] [Related]
10. Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
Watanabe T; Mitsukawa M; Horie S; Suga T; Seki K
J Pharmacobiodyn; 1987 Mar; 10(3):142-7. PubMed ID: 3625448
[TBL] [Abstract][Full Text] [Related]
11. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
12. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
[TBL] [Abstract][Full Text] [Related]
14. Effects of some hypolipidemic drugs on biochemical values and on hepatic peroxisomal enzymes of normolipemic rat.
Watanabe T; Manna H; Suga T
J Pharmacobiodyn; 1981 Oct; 4(10):743-50. PubMed ID: 6798192
[TBL] [Abstract][Full Text] [Related]
15. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters.
Cunningham ML
Toxic Rep Ser; 2007 Oct; (62):1-136. PubMed ID: 24743700
[TBL] [Abstract][Full Text] [Related]
16. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats.
Vainio H; Linnainmaa K; Kähönen M; Nickels J; Hietanen E; Marniemi J; Peltonen P
Biochem Pharmacol; 1983 Sep; 32(18):2775-9. PubMed ID: 6626247
[TBL] [Abstract][Full Text] [Related]
18. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
Fahl WE; Lalwani ND; Reddy MK; Reddy JK
Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
[TBL] [Abstract][Full Text] [Related]
19. Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice.
Reddy JK; Moody DE; Azarnoff DL; Rao MS
Life Sci; 1976 May; 18(9):941-5. PubMed ID: 1271963
[No Abstract] [Full Text] [Related]
20. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]